Protara Therapeutics, Inc. (TARA) Tops Q2 EPS by 5c
Tweet
Share
E-mailGet Alerts TARA Hot Sheet
Join SI Premium – FREE
Protara Therapeutics, Inc. (NASDAQ: TARA) reported Q2 EPS of ($0.35), $0.05 better than the analyst estimate of ($0.40).
For earnings history and earnings-related data on Protara Therapeutics, Inc. (TARA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- VNET Group (VNET) Misses Q2 EPS by 164c
- H.C. Wainwright Reiterates Buy Rating on Invivyd Inc. (IVVD)
- Mizuho Reiterates Outperform Rating on Uber Inc. (UBER)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
